"Precision Oncology Drug Portfolio Market Summary:
According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market
The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the...
According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...
According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...
The global Generic Oncology Drugs Market is witnessing steady expansion as healthcare systems worldwide prioritize cost-effective cancer treatment solutions. Generic oncology drugs, which are bioequivalent alternatives to branded cancer therapies, play a critical role in improving treatment accessibility and reducing healthcare expenditure. The increasing burden of cancer and the need for...
According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
According to a new report from Intel Market Research, the global Nimustine Hydrochloride market was valued at USD 78.5 million in 2024 and is projected to grow from USD 82.4 million in 2025 to USD 112.9 million by 2034, exhibiting a robust CAGR of 3.6% during the forecast period. Market growth is driven by increasing cancer prevalence, particularly in neurology and hematology applications,...
According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
Introduction
The testicular cancer drugs market is a crucial segment of the global oncology therapeutics industry, driven by advancements in cancer treatment and increasing awareness of early diagnosis. Testicular cancer, although relatively rare compared to other cancers, is one of the most common cancers among young men, particularly those between the ages of 15 and 35.
The growing focus on...
According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...
English
Indonesia
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek